Tags

Type your tag names separated by a space and hit enter

Disease modeling of core pre-mRNA splicing factor haploinsufficiency.
Hum Mol Genet. 2019 11 15; 28(22):3704-3723.HM

Abstract

The craniofacial disorder mandibulofacial dysostosis Guion-Almeida type is caused by haploinsufficiency of the U5 snRNP gene EFTUD2/SNU114. However, it is unclear how reduced expression of this core pre-mRNA splicing factor leads to craniofacial defects. Here we use a CRISPR-Cas9 nickase strategy to generate a human EFTUD2-knockdown cell line and show that reduced expression of EFTUD2 leads to diminished proliferative ability of these cells, increased sensitivity to endoplasmic reticulum (ER) stress and the mis-expression of several genes involved in the ER stress response. RNA-Seq analysis of the EFTUD2-knockdown cell line revealed transcriptome-wide changes in gene expression, with an enrichment for genes associated with processes involved in craniofacial development. Additionally, our RNA-Seq data identified widespread mis-splicing in EFTUD2-knockdown cells. Analysis of the functional and physical characteristics of mis-spliced pre-mRNAs highlighted conserved properties, including length and splice site strengths, of retained introns and skipped exons in our disease model. We also identified enriched processes associated with the affected genes, including cell death, cell and organ morphology and embryonic development. Together, these data support a model in which EFTUD2 haploinsufficiency leads to the mis-splicing of a distinct subset of pre-mRNAs with a widespread effect on gene expression, including altering the expression of ER stress response genes and genes involved in the development of the craniofacial region. The increased burden of unfolded proteins in the ER resulting from mis-splicing would exceed the capacity of the defective ER stress response, inducing apoptosis in cranial neural crest cells that would result in craniofacial abnormalities during development.

Authors+Show Affiliations

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester. Center for Genomic Medicine, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, St. Mary's Hospital, The University of Manchester, Manchester Academic Health Science Centre Manchester, M13 9PT, UK.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester. Center for Genomic Medicine, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, St. Mary's Hospital, The University of Manchester, Manchester Academic Health Science Centre Manchester, M13 9PT, UK.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester. Center for Genomic Medicine, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, St. Mary's Hospital, The University of Manchester, Manchester Academic Health Science Centre Manchester, M13 9PT, UK.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester. Center for Genomic Medicine, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, St. Mary's Hospital, The University of Manchester, Manchester Academic Health Science Centre Manchester, M13 9PT, UK.Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

31304552

Citation

Wood, Katherine A., et al. "Disease Modeling of Core pre-mRNA Splicing Factor Haploinsufficiency." Human Molecular Genetics, vol. 28, no. 22, 2019, pp. 3704-3723.
Wood KA, Rowlands CF, Qureshi WMS, et al. Disease modeling of core pre-mRNA splicing factor haploinsufficiency. Hum Mol Genet. 2019;28(22):3704-3723.
Wood, K. A., Rowlands, C. F., Qureshi, W. M. S., Thomas, H. B., Buczek, W. A., Briggs, T. A., Hubbard, S. J., Hentges, K. E., Newman, W. G., & O'Keefe, R. T. (2019). Disease modeling of core pre-mRNA splicing factor haploinsufficiency. Human Molecular Genetics, 28(22), 3704-3723. https://doi.org/10.1093/hmg/ddz169
Wood KA, et al. Disease Modeling of Core pre-mRNA Splicing Factor Haploinsufficiency. Hum Mol Genet. 2019 11 15;28(22):3704-3723. PubMed PMID: 31304552.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Disease modeling of core pre-mRNA splicing factor haploinsufficiency. AU - Wood,Katherine A, AU - Rowlands,Charlie F, AU - Qureshi,Wasay Mohiuddin Shaikh, AU - Thomas,Huw B, AU - Buczek,Weronika A, AU - Briggs,Tracy A, AU - Hubbard,Simon J, AU - Hentges,Kathryn E, AU - Newman,William G, AU - O'Keefe,Raymond T, PY - 2019/05/21/received PY - 2019/07/04/revised PY - 2019/07/08/accepted PY - 2019/7/16/pubmed PY - 2020/6/17/medline PY - 2019/7/16/entrez SP - 3704 EP - 3723 JF - Human molecular genetics JO - Hum Mol Genet VL - 28 IS - 22 N2 - The craniofacial disorder mandibulofacial dysostosis Guion-Almeida type is caused by haploinsufficiency of the U5 snRNP gene EFTUD2/SNU114. However, it is unclear how reduced expression of this core pre-mRNA splicing factor leads to craniofacial defects. Here we use a CRISPR-Cas9 nickase strategy to generate a human EFTUD2-knockdown cell line and show that reduced expression of EFTUD2 leads to diminished proliferative ability of these cells, increased sensitivity to endoplasmic reticulum (ER) stress and the mis-expression of several genes involved in the ER stress response. RNA-Seq analysis of the EFTUD2-knockdown cell line revealed transcriptome-wide changes in gene expression, with an enrichment for genes associated with processes involved in craniofacial development. Additionally, our RNA-Seq data identified widespread mis-splicing in EFTUD2-knockdown cells. Analysis of the functional and physical characteristics of mis-spliced pre-mRNAs highlighted conserved properties, including length and splice site strengths, of retained introns and skipped exons in our disease model. We also identified enriched processes associated with the affected genes, including cell death, cell and organ morphology and embryonic development. Together, these data support a model in which EFTUD2 haploinsufficiency leads to the mis-splicing of a distinct subset of pre-mRNAs with a widespread effect on gene expression, including altering the expression of ER stress response genes and genes involved in the development of the craniofacial region. The increased burden of unfolded proteins in the ER resulting from mis-splicing would exceed the capacity of the defective ER stress response, inducing apoptosis in cranial neural crest cells that would result in craniofacial abnormalities during development. SN - 1460-2083 UR - https://www.unboundmedicine.com/medline/citation/31304552/Disease_modeling_of_core_pre_mRNA_splicing_factor_haploinsufficiency_ DB - PRIME DP - Unbound Medicine ER -